Amedeo Smart

Free Medical Literature Service

 

Amedeo

Tuberculosis
  Free Subscription

Articles published in
AIDS
    March 2024
  1. HU FH, Tang XL, Ge MW, Jia YJ, et al
    Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis.
    AIDS. 2024 Mar 18. doi: 10.1097/QAD.0000000000003886.
    >> Share

    January 2024
  2. TSUKAMOTO T, Winslow DL
    Predicting tuberculosis at antiretroviral therapy initiation: the combination of monocyte-to-lymphocyte ratio and hemoglobin level may be a key.
    AIDS. 2024;38:115-117.
    >> Share

    November 2023
  3. CHERKOS AS, Cranmer LM, Njuguna I, LaCourse SM, et al
    Effect of TB-HIV co-treatment on clinical and growth outcomes among hospitalized children newly initiating antiretroviral therapy.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003797.
    >> Share

  4. PETERSON M, Briceno-Robaugh R, O'Connor S, Date A, et al
    Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief.
    AIDS. 2023;37:2103-2104.
    >> Share

    October 2023
  5. VAN GEUNS D, Arts RJ, de Vries G, Wit FW, et al
    Screening for tuberculosis infection and effectiveness of preventive treatment among people living with HIV in low-incidence settings: a systematic review and meta-analysis.
    AIDS. 2023 Oct 12. doi: 10.1097/QAD.0000000000003747.
    >> Share

  6. NIYONGABO B, Hira S
    Evaluation of the diagnostic efficacy of EC-test for latent tuberculosis infection in ambulatory people with HIV.
    AIDS. 2023;37:1899-1900.
    >> Share

  7. VENTER F, Niyongabo B
    Tuberculosis-HIV co-infection in an era of complex, rapid new drug development.
    AIDS. 2023;37:1897-1898.
    >> Share

    September 2023
  8. ONYANGO DO, van der Sande MAB, Yuen CM, Were J, et al
    Biomarker-confirmed suboptimal adherence to isoniazid preventive therapy among children living with HIV in western Kenya.
    AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003719.
    >> Share

  9. GATECHOMPOL S, Kerr SJ, Cardoso SW, Samaneka W, et al
    Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation.
    AIDS. 2023 Sep 11. doi: 10.1097/QAD.0000000000003713.
    >> Share

  10. HONG H, Dill-Mcfarland KA, Benson B, Simmons JD, et al
    Mtb-induced Monocyte Transcriptional Responses Associate with Resistance to TST/IGRA Conversion in PLWH.
    AIDS. 2023 Sep 11. doi: 10.1097/QAD.0000000000003716.
    >> Share

    August 2023
  11. BALASUBRAMANIAN R, Shearer K, Mudzengi D, Hippner P, et al
    Modeling the impact of universal TB molecular testing and timing of TB preventive treatment during ART initiation in South Africa.
    AIDS. 2023 Aug 30. doi: 10.1097/QAD.0000000000003707.
    >> Share

    July 2023
  12. KRAEF C, Bentzon A, Roen A, Bolokadze N, et al
    Long-term outcomes after tuberculosis for people with HIV in eastern Europe.
    AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003670.
    >> Share

    June 2023
  13. MASSMANN R, Groh T, Jilich D, Bartkova D, et al
    HIV-positive Ukrainian refugees in the Czech Republic: a retrospective, observational study.
    AIDS. 2023 Jun 22. doi: 10.1097/QAD.0000000000003633.
    >> Share

    May 2023
  14. HAHN JA, Ngabirano C, Fatch R, Emenyonu NI, et al
    Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use: a single arm trial.
    AIDS. 2023 May 30. doi: 10.1097/QAD.0000000000003613.
    >> Share

    April 2023
  15. CHONGXING Z, Yuanchun L, Yan H, Dabin L, et al
    Evaluation of the Diagnostic Efficacy of EC-Test for Latent Tuberculosis Infection in Ambulatory People Living with HIV.
    AIDS. 2023 Apr 20. doi: 10.1097/QAD.0000000000003573.
    >> Share

    March 2023
  16. TEMU TM, Polyak SJ, Wanjalla CN, Mandela NA, et al
    Latent tuberculosis is associated with heightened levels of pro-and anti-inflammatory cytokines among Kenyan men and women living with HIV on long-term antiretroviral therapy.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003523.
    >> Share

    February 2023
  17. DE CASTRO N, Chazallon C, Brites C, Messou E, et al
    Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high-TB burden countries.
    AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003521.
    >> Share

  18. CHAISSON LH, Semitala FC, Nangobi F, Steinmetz S, et al
    Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3HP.
    AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003508.
    >> Share

    December 2022
  19. ANTEL K, Oosthuizen J, Brown K, Malherbe F, et al
    Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis- and HIV-endemic region.
    AIDS. 2022 Dec 7. doi: 10.1097/QAD.0000000000003456.
    >> Share

  20. MITINI-NKHOMA SC, Mzinza DT, Chimbayo ET, Chirambo AP, et al
    Latent tuberculosis infection among adults attending HIV services at an urban tertiary hospital in Malawi.
    AIDS. 2022;36:2229-2231.
    >> Share

    November 2022
  21. JAGI JL, Thomas C, Gudi SK, Undela K, et al
    Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2022 Nov 23. doi: 10.1097/QAD.0000000000003436.
    >> Share

    August 2022
  22. WHITE HA, Baggaley RF, Okhai H, Patel H, et al
    The impact, effectiveness and outcomes of targeted screening thresholds for programmatic latent TB infection testing in HIV: cohort study results.
    AIDS. 2022 Aug 19. pii: 00002030-990000000-00096.
    >> Share

  23. FINK DL, Oladele DA, Slack AJ, Odubela O, et al
    A multicentre observational study of HIV, TB and risk of chronic lung disease in urban west Africa.
    AIDS. 2022 Aug 19. pii: 00002030-990000000-00093.
    >> Share

    July 2022
  24. GIRARDI E, Caro-Vega Y, Cozzi-Lepri A, Musaazi J, et al
    The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis: a 5-year estimate using real-world data.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00065.
    >> Share

    June 2022
  25. CHAISSON LH, Semitala FC, Mwebe S, Katende J, et al
    Transaminitis prevalence among HIV-infected adults eligible for tuberculosis preventive therapy.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00051.
    >> Share

  26. OLSSON O, Skogmar S, Tesfaye F, Mulleta D, et al
    Kynurenine/tryptophan ratio for detection of active tuberculosis in adults with HIV prior to antiretroviral therapy.
    AIDS. 2022 Jun 2. pii: 00002030-990000000-00026.
    >> Share

    May 2022
  27. VALINETZ ED, Matemo D, Gersh JK, Joudeh LL, et al
    Isoniazid preventive therapy and TB transcriptional signatures in people with HIV.
    AIDS. 2022 May 24. pii: 00002030-990000000-00017.
    >> Share

  28. NEL J, Gupta-Wright A
    Urine tuberculosis diagnostics in patients with advanced HIV.
    AIDS. 2022;36:897-898.
    >> Share

    April 2022
  29. VOGT SL, Maloma L, Xian RR, Ambinder RF, et al
    Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource setting.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00009.
    >> Share

    January 2022
  30. WAKE RM, Govender NP, Omar SV, Ismail F, et al
    Rapid urine-based screening tests increase the yield of same-day tuberculosis diagnoses among patients living with advanced HIV disease.
    AIDS. 2022 Jan 24. pii: 00002030-900000000-96230.
    >> Share

  31. ODENDAAL LN, Smit DP
    A triple case series of uveitis caused by HIV, syphilis and tuberculosis coinfection.
    AIDS. 2022;36:155-156.
    >> Share

  32. AUGUSTE PE, Mistry H, McCarthy ND, Sutcliffe PA, et al
    Cost-effectiveness of testing for latent tuberculosis infection in people with HIV.
    AIDS. 2022;36:1-9.
    >> Share

    December 2021
  33. NIKANJAM M, Tran L, Chadwick EG, Bwakura-Dangarembizi M, et al
    Impact of CYP2B6 genotype, TB therapy and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96261.
    >> Share

    September 2021
  34. KYAW NTT, Kumar AMV, Harries AD, Satyanarayana S, et al
    Synergy between low body mass index and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96306.
    >> Share

    July 2021
  35. WANG M, Boeke CE, Rioja MR, Maparo T, et al
    Feasibility and impact of near-point-of-care integrated TB/HIV testing in Malawi and Zimbabwe.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96342.
    >> Share

    June 2021
  36. PETERSON M, Sarita Shah N, Smith-Jeffcoat SE, Nichols C, et al
    Global progress and gaps in tuberculosis screening and treatment among people with HIV: experience from 32 countries.
    AIDS. 2021;35:1154-1156.
    >> Share

    February 2021
  37. WANG Y, Lin X, Wen Y
    Organizing pneumonia-presenting acute respiratory distress syndrome because of paradoxical tuberculosis-immune reconstitution disease?
    AIDS. 2021;35:351-354.
    >> Share

    November 2020
  38. HUAMAN MA, Juchnowski SM, Zidar DA, Kityo CM, et al
    Monocyte activation in persons living with HIV and tuberculosis coinfection.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002766.
    >> Share

    October 2020
  39. VONASEK B, Kay A, Devezin T, Bacha JM, et al
    Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002715.
    >> Share

    July 2020
  40. MEDINA N, Alastruey-Izquierdo A, Mercado D, Bonilla O, et al
    Comparative performance of the laboratory assays used by a diagnostic laboratory hub for opportunistic infections in people living with HIV.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002631.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016